• No results found

Cardiometabolic risk factors among HIV patients on antiretroviral therapy

N/A
N/A
Protected

Academic year: 2020

Share "Cardiometabolic risk factors among HIV patients on antiretroviral therapy"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Baseline characteristics of the DGPLEAD study overall and by combination antiretroviral therapy
Table 2 Lipid and metabolic changes from baseline to 90 days of combination antiretroviral therapy
Table 3 Comparison of metabolic changes by period and combination antiretroviral therapy regimen in the DGPLEAD study
Figure 1 Prevalence of abnormal lipid and otherwas no significant change (triglyceridescardiometabolic risk factors at baseline and 90 days followingcART initiation in the DGPLEAD study

References

Related documents

To assess the effects of intervention in cerebral palsy, 48 infants 12 to 19 months of age, with mild to severe spastic diplegia, were randomly assigned to receive either 6 months

In this section the problem assumptions and the proposed algorithm for mixed model assembly line balancing problem with stochastic processing time for maximizing

for industrial farming became more and more developed.” ( Tarcsay – Berta, 1974 ) Subsequent upon this, production systems appeared in the process of integration and

There was a sub acute oozing type of RV rupture with hemopericardium, the site of rupture being in the inf- arcted RV anterior wall below the outflow tract. The rup- ture

The following observations were noted based on Occupation distribution of study population (Figure 3): In oral cavity, oropharyngeal, laryngeal, sinonasal

• SRTM30 - A near-global DEM comprising a combination of data from the SRTMission, flown in February, 2000 and the GTOPO30 data set.... Tecniche CAD per le